Delivery Order SPE2DB22D3016-SPE2DB26FABR9
Award Date 11/7/25
Potential Completion Date 11/10/25
Potential Value $33K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for Act-o-Vials on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,187.44 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Act-O-Vials pharmaceutical products. This firm fixed price delivery order, with a completion date of November 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is...
- The Defense Logistics Agency awarded a delivery order valued at $3,331.73 to AmerisourceBergen Drug Corp on August 8, 2025, for ACT-O-VIALS pharmaceutical products. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,062.48 by the Defense Logistics Agency on November 5, 2025, for ACT-O-VIALS with an ultimate completion date of November 6, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $21,606.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and reflects the company's role as a critical vendor for military...
- The Defense Logistics Agency awarded a delivery order valued at $13,928.80 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 29, 2025, with completion targeted for September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on October 31, 2025, with an ultimate completion date of November 3, 2025. This firm fixed price contract is non-competitive and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...